Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zymeworks Inc (NY: ZYME )

N/A UNCHANGED
Last Price Updated: 7:00 PM EST, Dec 15, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 5.950 (3)
Ask (Size) 6.750 (1)
Prev. Close 6.430
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 57,771,204
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Zymeworks Announces Participation in Upcoming Investor Conferences
From Zymeworks Inc.
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Zymeworks, Regeneron, Jabil, and DoubleVerify and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Performance

More News

Read More
Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Zymeworks Inc. (ZYME)
From Kirby McInerney LLP
Via Business Wire
Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Via Benzinga
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
From Zymeworks Inc.
Via GlobeNewswire
ZYMEWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Zymeworks Inc. on Behalf of Zymeworks Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zymeworks Inc. (ZYME)
From Kirby McInerney LLP
Via GlobeNewswire
Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
From Zymeworks Inc.
Via GlobeNewswire
Next-Gen Winners: 7 Tech Stocks Set to Dominate the Decade
Via InvestorPlace
ZYME Stock Earnings: Zymeworks Beats EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting
From Zymeworks Inc.
Via GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
From Zymeworks Inc.
Via GlobeNewswire
Earnings Scheduled For March 6, 2024
Via Benzinga
3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List
Via InvestorPlace
Last Call! 7 Small-Cap Stocks Ready to Explode in Value
Via InvestorPlace
Zymeworks - Analysts Project A Big Turnaround
Via Talk Markets
7 Small-Cap Stocks With Significant Upside Potential in 2024
Via InvestorPlace
Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call
From Zymeworks Inc.
Via GlobeNewswire
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Names New Chief Financial Officer
Via Investor Brand Network
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors
From Zymeworks Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.